QCM
TXG icon

Quantinno Capital Management’s 10x Genomics TXG Stock Holding History

Quantinno Capital Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$115M Buy
5,411,761
+744,558
+16% +$14.9M 0.19% 64
2025
Q4 		$76.1M Buy
4,667,203
+1,174,744
+34% +$17.7M 0.15% 98
2025
Q3 		$40.8M Buy
3,492,459
+1,258,933
+56% +$16.4M 0.11% 190
2025
Q2 		$25.9M Buy
2,233,526
+1,506,530
+207% +$13.7M 0.11% 190
2025
Q1 		$6.35M Buy
726,996
+577,163
+385% +$7.28M 0.04% 550
2024
Q4 		$2.15M Sell
149,833
-85,193
-36% -$1.34M 0.02% 820
2024
Q3 		$5.31M Buy
235,026
+186,111
+380% +$3.85M 0.07% 335
2024
Q2 		$951K Buy
48,915
+25,852
+112% +$677K 0.02% 823
2024
Q1 		$866K Sell
23,063
-20,252
-47% -$890K 0.02% 778
2023
Q4 		$2.42M Buy
43,315
+33,902
+360% +$1.48M 0.08% 301
2023
Q3 		$388K Sell
9,413
-20,009
-68% -$1.04M 0.02% 802
2023
Q2 		$1.64M Buy
+29,422
New +$1.59M 0.09% 273

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quantinno Capital Management's TXG Position: Q1 2026 in Review

Quantinno Capital Management increased its 10x Genomics (TXG) stake by 16% in Q1 2026, buying an estimated $14.9M and bringing the position to 5,411,761 shares worth $115M. The position accounts for 0.19% of the portfolio, ranked #64.

Quantinno Capital Management first reported a position in TXG in Q2 2023 and has held it in 12 quarters since. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Quantinno Capital Management held 5,411,761 shares of 10x Genomics worth $115M as of Q1 2026.
  • Quantinno Capital Management bought 744,558 10x Genomics shares in Q1 2026, an estimated $14.9M.
  • 10x Genomics made up 0.19% of Quantinno Capital Management's portfolio in Q1 2026, its #64 holding.
  • Quantinno Capital Management first reported a position in 10x Genomics in Q2 2023 and has held it in 12 quarters since.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.